U.S. turns to GSK for extra doses of flu vaccine this season

U.S. officials have entered into an agreement with GlaxoSmithKline for 1.2 million doses of its Fluarix flu vaccine, to be made in Germany and supplied by the end of this month at a price of $7 per dose. The doses, which could reach a total of 4 million by the end of the season, were ordered after the FDA inspected GSK's German plant, but the agency has not officially approved the drug. Some members of Congress allege government hypocrisy in inspecting a foreign source for a single unapproved drug while continuing to ban imports of U.S.-approved prescription drugs from Canada and other countries.

View Full Article in:

Washington Post (tiered subscription model), The · Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director of Litigation
Center for Science in the Public Interest
Washington, DC
Health Plan CEO - Oregon
Trillium Community Health Plan
Eugene, OR
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Associate General Counsel
Patient-Centered Outcomes Research Institute
Washington, D.C , DC